These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5300692)

  • 1. [Crystallization of kallikrein-trypsin inhibitor as free, basic polypeptide].
    Schultz F
    Naturwissenschaften; 1967 Jul; 54(13):338. PubMed ID: 5300692
    [No Abstract]   [Full Text] [Related]  

  • 2. Crystallization and preliminary X-ray analysis of a Kunitz-type inhibitor, textilinin-1 from Pseudonaja textilis textilis.
    Millers EK; Masci PP; Lavin MF; de Jersey J; Guddat LW
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Jul; 62(Pt 7):642-5. PubMed ID: 16820682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined 2.5 A X-ray crystal structure of the complex formed by porcine kallikrein A and the bovine pancreatic trypsin inhibitor. Crystallization, Patterson search, structure determination, refinement, structure and comparison with its components and with the bovine trypsin-pancreatic trypsin inhibitor complex.
    Chen Z; Bode W
    J Mol Biol; 1983 Feb; 164(2):283-311. PubMed ID: 6188842
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the kinetics of the reaction between kallikrein inactivator and trypsin].
    Pütter J
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1197-206. PubMed ID: 5301336
    [No Abstract]   [Full Text] [Related]  

  • 5. Kallikrein inhibitors.
    Fritz H; Fink E; Truscheit E
    Fed Proc; 1979 Dec; 38(13):2753-9. PubMed ID: 315885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of microencapsulated proteinase inhibitor aprotinin.
    Larionova NV; Kazanskaya NF; Larionova NI; Ponchel G; Duchene D
    Biochemistry (Mosc); 1999 Aug; 64(8):857-62. PubMed ID: 10498799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of native and [homoserine lactone-52]-52,53-seco-bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor) to porcine pancreatic beta-kallikrein-B and bovine alpha-chymotrypsin: thermodynamic study.
    Oddone R; Barra D; Amiconi G; Ascenzi P; Tarricone C; Bolognesi M; Bortolotti F; Menegatti E
    J Mol Recognit; 1994 Mar; 7(1):39-46. PubMed ID: 7527234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman studies of the conformation of the basic pancreatic trypsin inhibitor.
    Brunner H; Holz M
    Biochim Biophys Acta; 1975 Feb; 379(2):408-17. PubMed ID: 235313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopped-flow kinetics of the resynthesis of the reactive site peptile bond in kallikrein inhibitor (Kunitz) by beta-trypsin.
    Quast U; Engel J; Steffen E; Tschesche H; Kupfer S
    Biochemistry; 1978 May; 17(9):1675-82. PubMed ID: 26384
    [No Abstract]   [Full Text] [Related]  

  • 10. Heterogeneity of the basic pancreatic inhibitor (Kunitz) in various bovine organs.
    Fioretti E; Binotti I; Barra D; Citro G; Ascoli F; Antonini E
    Eur J Biochem; 1983 Jan; 130(1):13-8. PubMed ID: 6186488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of water-insoluble derivatives of the trypsin-kallikrein inhibitor for the isolation of kallikrein and plasmin].
    Fritz H; Brey B; Schmal A; Werle E
    Hoppe Seylers Z Physiol Chem; 1969 May; 350(5):617-25. PubMed ID: 4239805
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human urinary kallikrein and to porcine pancreatic beta-kallikreins A and B.
    Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
    J Mol Biol; 1984 Jul; 176(3):425-30. PubMed ID: 6205156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of protease tissue inhibitor on the activity of pancreatic proteolytic enzymes in in-vitro experiments].
    Egorova EF; Chernoiarova OD; Ryzhkova GI
    Eksp Klin Farmakol; 1992; 55(3):39-41. PubMed ID: 1458161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of protein structure in the crystal and in solution. II. Tritium-hydrogen exchange of zinc-free and zinc insulin.
    Praissman M; Rupley JA
    Biochemistry; 1968 Jun; 7(6):2431-45. PubMed ID: 5690714
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on human salivary kallikrein. II. Properties of purified salivary kallikrein.
    Fujimoto Y; Moriwaki C; Moriya H
    J Biochem; 1973 Aug; 74(2):247-52. PubMed ID: 4543405
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of the kallikrein inhibitor against enzymes, IV. Behavior of the kallikrein inhibitor from bovine organs against trypsin and chymotrypsin].
    Kraut H; Bhargava N
    Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1500-1. PubMed ID: 5300803
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of trypsin inhibitor of a peptide-protein nature on kallikreins from human and rabbit blood stream].
    Paskhina TS; Krinskaia AV; Zykova VP
    Biokhimiia; 1975; 40(2):302-9. PubMed ID: 1081887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bauhinia bauhinioides plasma kallikrein inhibitor: interaction with synthetic peptides and fluorogenic peptide substrates related to the reactive site sequence.
    Oliva ML; Mendes CR; Santomauro-Vaz EM; Juliano MA; Mentele R; Auerswald EA; Sampaio MU; Sampaio CA
    Curr Med Chem; 2001 Jul; 8(8):977-84. PubMed ID: 11375765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of the interaction between trypsin and kallikrein inactivator by means of ultracentrifugation].
    Scholtan W
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1193-6. PubMed ID: 5301335
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of covalent binding of aprotinin with a polysaccharide carrier on its inhibition of kallikrein from human plasma, porcine pancreatic kallikrein and trypsin].
    Larionova NI; Makevnina LG; Nartikova VF; Paskhina TS
    Biokhimiia; 1987 May; 52(5):825-31. PubMed ID: 2439135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.